Furthermore, PDGF-B knockdown markedly reduced the MVD and CD31+ areas of 4T1 cancers compared with the control group (Fig. 7a and b), suggesting the angiogenic effect of tumoral PDGF-B level. This evidence concerns the gene PDGFB and cancer.